Biweekly pegylated liposomal doxorubicin as second-line treatment in patients with relapsed ovarian cancer after failure of platinum and paclitaxel: results from a multi-center phase II study of the NOGGO.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples